INBX Archived Articles
Inhibrx Biosciences (NASDAQ:INBX): A Resilient Biopharmaceutical Innovator Navigating the Complexities of the Oncology Landscape
Published on November 17, 2024
Inhibrx, Inc. (NASDAQ:INBX) - A Promising Biopharmaceutical Company with a Robust Pipeline and Exciting Developments
Published on September 24, 2024